My First Year. Our Culture. University and Placements. Flags Earned last year Conferences visited last year Team Sales Manager — Experienced Find Out More. Global Pharma — Freelance Clinical Director, Business Development, Clinical Sweden Clinical Consultant Needed — Business Development Manager — EU A Global Recruiter for the 21st Century. Find out More. In addition to the academic and scientific excellence, Canada has strength in the generation of intellectual property and in clinical development capabilities, which is demonstrated by the significant number of biopharmaceutical products in the pipeline.
Canada has one of the highest number of biotechnology companies in the world, with the majority focused on human health, giving Canada a strong record of achievement in biopharmaceuticals. Biopharmaceuticals hold great promise for treating some of the most intractable medical conditions such as cancer and autoimmune disease. The primary difference between biopharmaceuticals and traditional pharmaceuticals is the method by which the drugs are produced: The former are manufactured in living organisms such as bacteria, yeast and mammalian cells, whereas the latter are manufactured through a series of chemical synthesis.
Biopharmaceuticals are primarily developed in both academic and industrial laboratories. The commercialisation process is often funded by venture capital firms for academic and start-ups or drug companies. Biotech opportunities largely mirror those in the pharmaceutical industry. The key difference is that biotech firms are much more focused on research because they are still developing their initial products.
Biotech firms tend to expand their marketing and sales forces when, and if a viable product nears FDA approval. Biotech companies tend to be located in geographical clusters, often near prominent research universities. The biopharmaceutical industry and pharmaceutical industry differ in several ways. The main difference comes down to product manufacturing. Biopharmaceutical products are manufactured in living organisms, including white blood cells or bacteria.
On the flip side, pharmaceutical products are manufactured using chemical-based processes. Both of these product categories assist in the prevention and treatment of all communicable and non-communicable diseases, including infectious, genetic, and physiological diseases.
Biopharmaceutical and pharmaceutical products share many of the same handling requirements. For example, both must be stored in temperature-controlled environments. Manufacturers must also ensure that storage facilities are thoroughly decontaminated.
Biopharmaceutical products are prone to microbial contamination.
0コメント